Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph M Meyer

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Hematology/Oncology Clinics of North America|November 30, 2013
Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy aloneAnnette E Hay, Ralph M Meyer
Hematology. American Society of Hematology. Education Program|December 13, 2012
Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapyRalph M Meyer, Richard T Hoppe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2012
Hepatitis B, rituximab, screening, and prophylaxis: effectiveness and cost effectivenessAnnette E Hay, Ralph M Meyer
Blood|July 24, 2012
Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapyRalph M Meyer, Richard T Hoppe
Annals of Internal Medicine|April 17, 2002
The role of high-dose chemotherapy and stem-cell transplantation in patients with multiple myeloma: a practice guideline of the Cancer Care Ontario Practice Guidelines InitiativeKevin Imrie, Rosmin Esmail, Ralph M Meyer, et al.
Biomarkers in Medicine|May 19, 2010
Biomarkers and the design of clinical trials in cancerGraeme A M Fraser, Ralph M Meyer
JAMA Oncology|June 5, 2020
Registry Data and Conditioning Therapy for Allogeneic Hematopoietic Cell Transplant and LymphomaTobias Berg, Hira S Mian, Ralph M Meyer
Hematology. American Society of Hematology. Education Program|November 25, 2004
Hodgkin's lymphoma: evolving concepts with implications for practiceRalph M Meyer, Richard F Ambinder, Sigrid Stroobants
Annals of Internal Medicine|January 16, 2002
Chemotherapy for older patients with newly diagnosed, advanced-stage, aggressive-histology non-Hodgkin lymphoma: a systematic reviewC Tom Kouroukis, George P Browman, Rosmin Esmail, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 14, 2011
Cooperative Group Cancer Clinical Trials: An NCIC Clinical Trials Group PerspectiveRalph M Meyer, Heather A Stanton, Wendy R Parulekar, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Hematology/Oncology Clinics of North America|November 30, 2013
Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy aloneAnnette E Hay, Ralph M Meyer
Hematology. American Society of Hematology. Education Program|December 13, 2012
Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapyRalph M Meyer, Richard T Hoppe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2012
Hepatitis B, rituximab, screening, and prophylaxis: effectiveness and cost effectivenessAnnette E Hay, Ralph M Meyer
Blood|July 24, 2012
Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapyRalph M Meyer, Richard T Hoppe
Annals of Internal Medicine|April 17, 2002
The role of high-dose chemotherapy and stem-cell transplantation in patients with multiple myeloma: a practice guideline of the Cancer Care Ontario Practice Guidelines InitiativeKevin Imrie, Rosmin Esmail, Ralph M Meyer, et al.
Biomarkers in Medicine|May 19, 2010
Biomarkers and the design of clinical trials in cancerGraeme A M Fraser, Ralph M Meyer
JAMA Oncology|June 5, 2020
Registry Data and Conditioning Therapy for Allogeneic Hematopoietic Cell Transplant and LymphomaTobias Berg, Hira S Mian, Ralph M Meyer
Hematology. American Society of Hematology. Education Program|November 25, 2004
Hodgkin's lymphoma: evolving concepts with implications for practiceRalph M Meyer, Richard F Ambinder, Sigrid Stroobants
Annals of Internal Medicine|January 16, 2002
Chemotherapy for older patients with newly diagnosed, advanced-stage, aggressive-histology non-Hodgkin lymphoma: a systematic reviewC Tom Kouroukis, George P Browman, Rosmin Esmail, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 14, 2011
Cooperative Group Cancer Clinical Trials: An NCIC Clinical Trials Group PerspectiveRalph M Meyer, Heather A Stanton, Wendy R Parulekar, et al.
Pageof 9